How is the Systemic Immune‑Inflammation Index (SII) calculated and what are the reference level categories?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Systemic Immune-Inflammation Index (SII): Calculation and Reference Levels

The Systemic Immune-Inflammation Index (SII) is calculated as: (Platelet count × Neutrophil count) / Lymphocyte count, using absolute counts from a standard complete blood count.

Calculation Formula

The SII integrates three key hematological parameters into a single composite inflammatory marker 1, 2, 3:

  • SII = (Platelets × Neutrophils) / Lymphocytes
  • All values use absolute counts (cells/μL or ×10⁹/L)
  • Derived from routine complete blood count (CBC) testing
  • No additional laboratory costs or specialized testing required

Reference Levels and Clinical Thresholds

Healthy Population Reference Range

  • Normal reference interval: 180-1,392 × 10⁹/L (95% reference interval from healthy controls) 4
  • Median in healthy individuals: approximately 516 × 10⁹/L 4

Disease-Specific Cutoff Values

The optimal SII threshold varies substantially by clinical context, reflecting different pathophysiological processes:

Cardiovascular Disease:

  • STEMI (myocardial infarction): ≥914 predicts large infarct size (≥20% of left ventricular mass) with 74% sensitivity and specificity 1
  • Complete AV block in STEMI: ≥1,117.7 with 70.8% sensitivity and 65.6% specificity 5
  • Contrast-induced nephropathy in NSTEMI: ≥709 with 74% sensitivity and specificity 3

Inflammatory/Rheumatic Diseases:

  • Crohn's disease (penetrating type): ≥1,745.85 with 61.5% sensitivity and 78.3% specificity 2
  • Rheumatic diseases generally: Significantly elevated (standardized mean difference 0.83) compared to healthy controls, though specific thresholds vary by disease subtype 6

Critical Care:

  • Mortality prediction in critically ill dogs: ≥2,628 (AUC 0.806; 90% sensitivity, 74.5% specificity) - included as comparative veterinary data 4
  • Emergency department hospitalization risk: Higher values associated with increased risk, though standalone discrimination modest (AUC 0.640); most valuable when combined with NEWS2 score 7

Acute Ischemic Stroke:

  • Poor functional outcome after thrombectomy: Elevated SII (AUC 0.834 as standalone predictor) 8

Clinical Interpretation Framework

When evaluating SII results, apply this algorithmic approach:

  1. Compare to normal range (180-1,392): Values below this range suggest potential immunosuppression or bone marrow dysfunction; values above indicate systemic inflammation

  2. Apply disease-specific thresholds: Use the context-appropriate cutoff based on the clinical scenario (e.g., 914 for STEMI, 1,745 for penetrating Crohn's disease)

  3. Integrate with established markers: SII performs best when combined with traditional inflammatory markers (CRP, ESR) and clinical scoring systems rather than used in isolation 7

  4. Consider temporal trends: Serial measurements may provide more value than single time-point assessments for monitoring disease activity

Important Caveats

  • SII thresholds are not interchangeable across conditions - a value of 1,000 may be high-risk in one disease but moderate in another
  • Standalone discrimination is often modest - SII should complement, not replace, established diagnostic criteria and disease activity scores 6, 7
  • No standardized universal cutoff exists - each clinical application requires validation of disease-specific thresholds
  • Values can be influenced by acute infections, medications (especially corticosteroids), and other conditions affecting white blood cell or platelet counts

The SII represents a practical, cost-effective inflammatory biomarker that requires no additional testing beyond routine CBC, but its clinical utility depends heavily on using validated, context-specific thresholds rather than applying a single universal cutoff value.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.